The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents.
about
Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor model.Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.Potential of Mesenchymal Stem Cell based application in CancerSystemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells.Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice.The gap between the physiological and therapeutic roles of mesenchymal stem cells.Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity.Mesenchymal stem cell-based gene therapy: A promising therapeutic strategy.Tumor-associated mesenchymal stem cells inhibit naïve T cell expansion by blocking cysteine export from dendritic cells.Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives.Short and long term fate of human AMSC subcutaneously injected in mice.Endoglin (CD105) is not a specific selection marker for endothelial cells in human islets of Langerhans. Reply to Wheeler-Jones CPD, Clarkin CE, Farrar CE et al [letter].Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model.Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells.IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors.
P2860
Q30420262-3048709C-9F1F-4198-8109-9D1CE86C456CQ33975595-E1A4AD4E-9B34-4F3C-97B4-EB34AE565282Q35540034-FEBA6825-49E5-4E00-BCBA-5228F7014CE0Q37073094-EEB30E0D-E391-4565-BF77-3A4A39C813A5Q37365677-1EFF50D1-6172-4D99-9651-F1FD3AD91403Q37640522-B9DDD102-1780-4D22-B480-CE76E8832651Q38215374-A04639A2-9107-43F7-A567-43AD7440165EQ38261603-44CD8E40-B4BD-4BD3-8274-66FE50692A9FQ38543181-3A6DC92D-DCEE-433A-8604-99E353C615D0Q38758544-866E7F45-548F-4B2F-9C30-E6CBA1D097DFQ39356683-A5911AF3-7720-4C44-8BBE-CB498280B4FDQ42871852-4314D902-16E9-4105-99E1-4F5F5DB5948AQ45214387-EC04A464-9481-4B0C-95DC-7E83B17776FDQ45876898-CC0F58CB-0F46-4C8D-AE52-5687D44219E3Q50433971-802E6CC2-F0A2-46D8-85D4-F364319EF695Q55502636-2CCD5A78-88B0-47FF-9014-90ABABDC9FEB
P2860
The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The bad and the good of mesenc ...... delivery of anticancer agents.
@ast
The bad and the good of mesenc ...... delivery of anticancer agents.
@en
The bad and the good of mesenc ...... delivery of anticancer agents.
@nl
type
label
The bad and the good of mesenc ...... delivery of anticancer agents.
@ast
The bad and the good of mesenc ...... delivery of anticancer agents.
@en
The bad and the good of mesenc ...... delivery of anticancer agents.
@nl
prefLabel
The bad and the good of mesenc ...... delivery of anticancer agents.
@ast
The bad and the good of mesenc ...... delivery of anticancer agents.
@en
The bad and the good of mesenc ...... delivery of anticancer agents.
@nl
P2860
P356
P1476
The bad and the good of mesenc ...... delivery of anticancer agents
@en
P2093
Antonio Giordano
P2860
P356
10.4252/WJSC.V2.I1.5
P577
2010-02-01T00:00:00Z